BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 23589995)

  • 41. Cervical cytology in Zambia.
    Grech ES; O'Dowd MJ; Tsirkina GA; Zeigler O
    Med J Zambia; 1977; 11(4):112-7. PubMed ID: 919781
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effectiveness of an organized cervical cancer screening program in Korea: results from a cohort study.
    Jun JK; Choi KS; Jung KW; Lee HY; Gapstur SM; Park EC; Yoo KY
    Int J Cancer; 2009 Jan; 124(1):188-93. PubMed ID: 18785204
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening patterns within organized programs and survival of Italian women with invasive cervical cancer.
    Zucchetto A; Ronco G; Giorgi Rossi P; Zappa M; Ferretti S; Franzo A; Falcini F; Visioli CB; Zanetti R; Biavati P; La Rosa F; Baracco S; Federico M; Campari C; De Togni A; Piffer S; Pannozzo F; Fusco M; Michiara M; Castaing M; Seghini P; Tisano F; Serraino D;
    Prev Med; 2013 Sep; 57(3):220-6. PubMed ID: 23732239
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Why lesbians should be encouraged to have regular cervical screening.
    Henderson HJ
    J Fam Plann Reprod Health Care; 2009 Jan; 35(1):49-52. PubMed ID: 19126320
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cervical cancer in women under 25 years of age in Queensland, Australia: To what extent is the diagnosis made by screening cytology?
    Morgan EL; Sanday K; Budd A; Hammond IG; Nicklin J
    Aust N Z J Obstet Gynaecol; 2017 Aug; 57(4):469-472. PubMed ID: 28580578
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Colposcopy attendance and deprivation: A retrospective analysis of 27,193 women in the NHS Cervical Screening Programme.
    Douglas E; Wardle J; Massat NJ; Waller J
    Br J Cancer; 2015 Jun; 113(1):119-22. PubMed ID: 25996205
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Progression of 189 women diagnosed with uterine cervical dysplasia based on abnormal results in mass screening.
    Muramatsu T; Yoshitake T; Iida T; Yamashita E; Hirasawa T; Miyamoto T; Murakami M; Matsui N; Kajiwara H; Yasuda M; Osamura RY; Mikami M
    Tokai J Exp Clin Med; 2006 Dec; 31(4):141-5. PubMed ID: 21302243
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.
    Schiffman M; Kinney WK; Cheung LC; Gage JC; Fetterman B; Poitras NE; Lorey TS; Wentzensen N; Befano B; Schussler J; Katki HA; Castle PE
    J Natl Cancer Inst; 2018 May; 110(5):501-508. PubMed ID: 29145648
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The impact of Jade Goody's diagnosis and death on the NHS Cervical Screening Programme.
    Lancucki L; Sasieni P; Patnick J; Day TJ; Vessey MP
    J Med Screen; 2012 Jun; 19(2):89-93. PubMed ID: 22653575
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improving the uptake of cervical screening in pregnant and recently postnatal women: a quality improvement project.
    Coleridge SL; Wiggans A; Nelissen E; Bethune R; Blackwell R; Bryant A; Morrison J
    BMJ Open Qual; 2022 May; 11(2):. PubMed ID: 35613829
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Knowledge and experience of a cohort of HIV-positive and HIV-negative Ghanaian women after undergoing human papillomavirus and cervical cancer screening.
    Stuart A; Obiri-Yeboah D; Adu-Sarkodie Y; Hayfron-Benjamin A; Akorsu AD; Mayaud P
    BMC Womens Health; 2019 Oct; 19(1):123. PubMed ID: 31647013
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Self-administered versus provider-directed sampling in the Anishinaabek Cervical Cancer Screening Study (ACCSS): a qualitative investigation with Canadian First Nations women.
    Zehbe I; Wakewich P; King AD; Morrisseau K; Tuck C
    BMJ Open; 2017 Sep; 7(8):e017384. PubMed ID: 28864487
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cervical cancer in women aged less than 25: East Kent experience.
    Nair MS; Bhandari HM; Nordin AJ
    J Obstet Gynaecol; 2007 Oct; 27(7):706-8. PubMed ID: 17999298
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of media reporting of cervical cancer in a UK celebrity on a population-based cervical screening programme.
    MacArthur GJ; Wright M; Beer H; Paranjothy S
    J Med Screen; 2011; 18(4):204-9. PubMed ID: 22156146
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Review of invasive cervical cancers and uptake of disclosure of results: an audit of procedures and response.
    Prabakar I; Moss EL; Douce G; Parkes J; Redman CW
    Cytopathology; 2012 Jun; 23(3):167-71. PubMed ID: 22494343
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Invasive cancer of the cervix in British Columbia: a review of the demography and screening histories of 437 cases seen from 1985-1988.
    Anderson GH; Benedet JL; Le Riche JC; Matisic JP; Thompson JE
    Obstet Gynecol; 1992 Jul; 80(1):1-4. PubMed ID: 1603476
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Invasive cancer of the cervix: does the UK National Health Service screening programme fail due to patients' non-attendance?
    Clement KM; Mansour D
    Eur J Gynaecol Oncol; 2013; 34(1):28-30. PubMed ID: 23589995
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Review of the screening history of Alberta women with invasive cervical cancer.
    Stuart GC; McGregor SE; Duggan MA; Nation JG
    CMAJ; 1997 Sep; 157(5):513-9. PubMed ID: 9294389
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.